Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Taipei Medical University WanFang Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01322685
First received: March 23, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted
  Purpose

The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.


Condition
Tuberculosis
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

Resource links provided by NLM:


Further study details as provided by Taipei Medical University WanFang Hospital:

Estimated Enrollment: 40
Study Start Date: July 2010
Estimated Study Completion Date: June 2011
Groups/Cohorts
Health Group
Tuberculosis Group
Tuberculosis or lung cancer group

  Eligibility

Ages Eligible for Study:   17 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Health people Tuberculosis or lung cancer

Criteria

Inclusion Criteria:

  • Health group: between 17 to 90 years old
  • Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old

Exclusion Criteria:

  • Women subjects are before or after the period within two days
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01322685

Locations
Taiwan
Taipei Medical University - WanFang Hospital
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
Principal Investigator: Kuo-Sheng Hung Taipei Medical University WanFang Hospital
  More Information

No publications provided

Responsible Party: Kuo-Sheng Hung, Department of Neurosurgery, WanFang Hospital
ClinicalTrials.gov Identifier: NCT01322685     History of Changes
Other Study ID Numbers: 99042
Study First Received: March 23, 2011
Last Updated: March 23, 2011
Health Authority: Taiwan: Department of Health

Keywords provided by Taipei Medical University WanFang Hospital:
Tuberculosis
Lung cancer

Additional relevant MeSH terms:
Lung Neoplasms
Tuberculosis
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Lung Diseases
Mycobacterium Infections
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms

ClinicalTrials.gov processed this record on October 22, 2014